Astera Labs (NASDAQ:ALAB) Now Covered by UBS Group

UBS Group began coverage on shares of Astera Labs (NASDAQ:ALAB) in a report released on Tuesday, MarketBeat Ratings reports. The firm issued a hold rating on the stock.

Other equities research analysts also recently issued research reports about the company. Royal Bank Of Canada restated an “outperform” rating and set a $250.00 target price on shares of Astera Labs in a research report on Tuesday. Barclays set a $165.00 target price on Astera Labs in a research report on Thursday, January 15th. Citigroup assumed coverage on Astera Labs in a research report on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price on the stock. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Finally, Loop Capital assumed coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $199.74.

Astera Labs Stock Down 1.5%

Astera Labs stock traded down $2.92 during trading on Tuesday, hitting $189.05. The stock had a trading volume of 2,156,984 shares, compared to its average volume of 5,273,051. Astera Labs has a 1 year low of $59.32 and a 1 year high of $262.90. The stock’s 50 day moving average is $129.78 and its two-hundred day moving average is $153.49. The stock has a market cap of $32.38 billion, a price-to-earnings ratio of 154.71, a price-to-earnings-growth ratio of 3.46 and a beta of 1.78.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue for the quarter was up 91.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts anticipate that Astera Labs will post 1.48 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares in the company, valued at approximately $12,725,912.68. The trade was a 7.81% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,064,888 shares of company stock valued at $150,764,723. Corporate insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Nordea Investment Management AB bought a new position in Astera Labs in the fourth quarter valued at $2,028,000. Geneva Partners LLC bought a new position in Astera Labs in the third quarter valued at $1,876,000. Numerai GP LLC increased its stake in Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares during the last quarter. Handelsbanken Fonder AB increased its stake in Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after acquiring an additional 93,800 shares during the last quarter. Finally, Corient Private Wealth LLC bought a new position in Astera Labs in the second quarter valued at $543,000. Institutional investors own 60.47% of the company’s stock.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Hyperscaler/customer momentum — coverage links Astera to a large Amazon‑Anthropic commitment that analysts say will drive multi‑year demand for CXL/PCIe retimers and related connectivity gear, supporting expectations for follow‑on orders. Read More.
• Positive Sentiment: Analyst price‑target upgrades — RBC and others issued double‑digit price target raises (RBC $250 PT cited), which has lifted sentiment ahead of earnings and likely attracted momentum buyers. Read More.
• Positive Sentiment: Fundamentals and guidance — recent quarterly results showed +91.8% revenue growth and an EPS beat; management set Q1 guidance of $0.530–$0.540, underpinning bullish analyst views and validating the “picks‑and‑shovels” AI narrative. Read More.
• Neutral Sentiment: Broker initiation/coverage mix — UBS started coverage at “hold” (neutral) while other firms have buy/outperform views; mixed initiation can temper upside but also broadens analyst focus. Read More.
• Neutral Sentiment: Momentum and hedge‑fund interest — technical buy signals and hedge‑fund flows are amplifying intraday moves; these factors increase volatility and can accelerate rallies or reversals. Read More.
• Negative Sentiment: Insider selling — CEO Jitendra Mohan and a director disclosed sizeable sales executed under pre‑arranged Rule 10b5‑1 plans (recent multi‑block sales include a large Apr 17 transaction). While planned sales reduce governance alarm, they can be perceived negatively by momentum investors. Read More.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.